Stay updated on LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page.

Latest updates to the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page
- Check6 days agoChange DetectedDifference2%
- Check13 days agoChange DetectedThe page has removed detailed information about a Phase 1 clinical trial for LAVA-051, including key inclusion and exclusion criteria for participants, while adding a new revision number.SummaryDifference22%
- Check20 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has been changed from March 25, 2025, to January 27, 2025.SummaryDifference2%
- Check28 days agoChange DetectedThe page has removed references to Acute Graft Versus Host Disease and added information about Multiple Myeloma.SummaryDifference0.3%
- Check35 days agoChange DetectedDifference1%
- Check42 days agoChange DetectedDifference0.7%
Stay in the know with updates to LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LAVA-051 in Relapsed/Refractory Hematologic Malignancies Clinical Trial page.